Pentagon Backs IperionX (ASX:IPX) with US$146M: A Buy Signal for Titanium Investors?

America has a titanium problem. By 2023, the United States had become 100% reliant on imported titanium sponge, the raw material essential for fighter jets, commercial aircraft, and defence systems. Even more concerning, China now controls roughly 67% of global titanium sponge production, up from just 40% in 2018. This dramatic shift has turned titanium into a national security priority, prompting the Pentagon to pour funding into domestic alternatives. Among the beneficiaries is ASX-listed IperionX (ASX: IPX), which has secured US government contracting capacity of over US$146 million, providing a multi-year runway to help rebuild America's titanium supply chain.

Why Titanium Is a Strategic Priority

Titanium is not just another industrial metal. Its unique combination of strength, light weight, and corrosion resistance makes it irreplaceable in aerospace and defence applications. According to Mordor Intelligence, aerospace and defence account for over 52% of global titanium demand. Modern fighter jets like the F-35 Lightning II rely heavily on titanium for structural components, while commercial aircraft like the Boeing 787 and Airbus A350 each incorporate over 70 metric tonnes of the metal.

The global aerospace titanium market is projected to reach US$4 billion by 2030, growing at approximately 6-7% annually according to multiple industry reports. This growth is underpinned by record aircraft order backlogs and increasing defence spending worldwide. For investors, titanium exposure has shifted from a niche materials play to a geopolitically significant opportunity.

‍

A Supply Chain Under Pressure

The US titanium supply chain has deteriorated significantly over the past decade. According to the US Geological Survey (USGS), America's last commercial titanium sponge facility was idled in 2020, leaving the country entirely dependent on imports. While Japan remains the primary supplier (67% of US imports in 2024), the broader picture is troubling. China has aggressively expanded its titanium production capacity, tripling output since 2018 to dominate global supply.

The Russia-Ukraine conflict has added further complexity. Russia was historically a major titanium supplier to Western aerospace manufacturers, but sanctions and geopolitical tensions have disrupted these supply chains. Boeing and Airbus have scrambled to diversify their sourcing, while global aircraft backlogs have reached record levels.

In March 2025, President Trump signed an executive order invoking the Defence Production Act to accelerate domestic critical mineral production, including titanium. This Cold War-era legislation gives the government broad powers to direct industrial production for national security purposes. The Pentagon has since obligated tens of millions of dollars toward rebuilding domestic titanium capacity.

For investors seeking exposure to critical minerals themes, ASR's free Top-3 Stocks & Market Outlook Report provides analysis of companies positioned to benefit from these structural supply shifts.

IperionX: Positioned at the Centre of US Titanium Reshoring

IperionX (ASX: IPX) has emerged as a key player in America's titanium reshoring efforts. The company has secured substantial government backing, including a US$47.1 million Department of Defence (DoD) contract and a US$99 million SBIR Phase III contract ceiling, establishing a formal framework for the Pentagon to procure IperionX's titanium products over the coming years.

The company's Virginia Titanium Manufacturing Campus is currently scaling production, with plans to reach 1,400 metric tonnes per year (tpa) by mid-2027. IperionX's proprietary HAMR (Hydrogen Assisted Metallothermic Reduction) technology offers potential advantages over traditional titanium production methods, including lower energy consumption and the ability to use recycled titanium scrap as feedstock.

However, investors should consider the risks. While IperionX has historically relied on equity raises to fund its rapid scale-up, management projects a positive EBITDA inflection point by year-end 2026 as the Virginia facility approaches its 1,400 tpa target, though execution risks remain. Scaling from demonstration to commercial production presents execution challenges, and the company faces competition from other domestic initiatives. The recent share price has reflected both enthusiasm for the government contracts and typical small-cap volatility.

Investor Takeaway

Key considerations for investors evaluating titanium exposure:

Macro tailwind: US titanium supply chain vulnerability has created a structural opportunity, with government funding flowing toward domestic production solutions.

Company positioning: IperionX has secured significant government contracts and is advancing production scale-up, though commercial success remains dependent on execution.

Key risks: Scaling challenges, ongoing funding requirements, competition from other domestic players, and typical small-cap volatility warrant careful consideration.

The titanium sector's transformation from a niche industrial material to a geopolitical flashpoint has created both opportunity and complexity for investors. Those seeking further research on critical minerals and the resources sector trends can explore ASR's market analysis and portfolio coverage for deeper insights.

‍

‍

‍

Ready to explore critical mineral opportunities? Download ASR's free Top-3 Stocks & Market Outlook Report for actionable research and market insights.

‍

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research and consider their individual circumstances before making investment decisions.

‍